1.Yamamoto T, et al. Community-acquired methicillin-resistant Staphylococcus aureus: community transmission, pathogenesis, and drug resistance. Journal of Infection and Chemotherapy 2010; 16: 225–254.
2.Ito T, et al. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 2001; 45: 1323–1336.
3.Garza-Gonzalez E, et al. Diversity of staphylococcal chromosome mec structures in coagulase-negative staphylococci and relationship to drug resistance. Journal of Medical Microbiology 2010; 59: 323–329.
4.Barbier F, et al. Methicillin-resistant coagulase-negative staphylococci in the community: high homology of SCCmec IVa between Staphylococcus epidermidis and major clones of methicillin-resistant Staphylococcus aureus. Journal of Infectious Diseases 2010; 202: 270–281.
5.Deurenberg RH, Stobberingh EE. The molecular evolution of hospital- and community-associated methicillin-resistant Staphylococcus aureus. Current Molecular Medicine 2009; 9: 100–115.
6.Na'was T, Fakhoury J. Nasal carriage of methicillin resistant Staphylococcus aureus by hospital staff in Jordan. Journal of Hospital Infection 1991; 17: 223–229.
7.Al-Zu'bi E, Bdour S, Shehabi AA. Antibiotic resistance patterns of mecA-positive Staphylococcus aureus isolates from clinical specimens and nasal carriage. Microbial Drug Resistance 2004; 10: 321–324.
8.Daghistani HI, Issa AA, Shehabi AA. Frequency of nasal and wound isolates of Staphylococcus aureus associated with TSST-1 production in Jordanian population. FEMS Immunology and Medical Microbiology 2000; 27: 95–98.
9.Khalil W, et al. Methicillin-resistant Staphylococcus aureus ST80-IV clone in children from Jordan. Diagnostic Microbiology and Infectious Disease 2012; 73: 228–230.
10.Diep BA, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006; 367: 731–739.
11.Archer GL, Niemeyer DM. Origin and evolution of DNA associated with resistance to methicillin in staphylococci. Trends in Microbiology 1994; 2: 343–347.
12.Chen CS, Chen CY, Huang YC. Nasal carriage rate and molecular epidemiology of methicillin-resistant Staphylococcus aureus among medical students at a Taiwanese university. International Journal of Infectious Diseases 2012; 16: e799–803.
13.Prates KA, et al. Nasal carriage of methicillin-resistant Staphylococcus aureus in university students. Brazilian Journal of Infectious Diseases 2010; 14: 316–318.
14.von Eiff C, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. New England Journal of Medicine 2001; 344: 11–16.
15.Brakstad OG, Aasbakk K, Maeland JA. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. Journal of Clinical Microbiology 1992; 30: 1654–1660.
16.Martineau F, et al. Species-specific and ubiquitous DNA-based assays for rapid identification of Staphylococcus epidermidis. Journal of Clinical Microbiology 1996; 34: 2888–2893.
17.Milheirico C, Oliveira DC, de Lencastre H. Update to the multiplex PCR strategy for assignment of mec element types in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 2007; 51: 3374–3377.
18.Milheirico C, Oliveira DC, de Lencastre H. Multiplex PCR strategy for subtyping the staphylococcal cassette chromosome mec type IV in methicillin-resistant Staphylococcus aureus: ‘SCCmec IV multiplex’. Journal of Antimicrobial Chemotherapy 2007; 60: 42–48.
19.Lina G, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical Infectious Diseases 1999; 29: 1128–1132.
20.Jarraud S, et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infection and Immunity 2002; 70: 631–641.
21.Oliveira DC, Tomasz A, de Lencastre H. The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. Microbial Drug Resistance 2001; 7: 349–361.
22.Shopsin B, et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. Journal of Clinical Microbiology 1999; 37: 3556–3563.
23.Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: fifteenth information supplement M110-S15. CLSI, 2005, Wayne, PA, USA.
24.Borg MA, et al. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries. Journal of Antimicrobial Chemotherapy 2007; 60: 1310–1315.
25.Borg MA, et al. Antibiotic resistance in the southern Mediterranean-preliminary results from the ARMed project. Eurosurveillance 2006; 11: 164–167.
26.Al-Bakri AG, Bustanji Y, Yousef AM. Community consumption of antibacterial drugs within the Jordanian population: sources, patterns and appropriateness. International Journal of Antimicrobial Agents 2005; 26: 389–395.
27.Al-Momany NH, et al. Adherence to international antimicrobial prophylaxis guidelines in cardiac surgery: a Jordanian study demonstrates need for quality improvement. Journal of Managed Care Pharmacy 2009; 15: 262–271.
28.Halablab MA, et al. Staphylococcus aureus nasal carriage rate and associated risk factors in individuals in the community. Epidemiology and Infection 2010; 138: 702–706.
29.Alghaithy AA, et al. Nasal carriage and antibiotic resistance of Staphylococcus aureus isolates from hospital and non-hospital personnel in Abha, Saudi Arabia. Transactions of the Royal Society Tropical Medicine and Hygiene 2000; 94: 504–507.
30.Tokajian ST, et al. Molecular characterization of Staphylococcus aureus in Lebanon. Epidemiology and Infection 2010; 138: 707–712.
31.Otter JA, French GL. Utility of antimicrobial susceptibility-based algorithms for the presumptive identification of genotypically-defined community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital. European Journal of Clinical Microbiology and Infectious Disease 2011; 30: 459–463.
32.Takizawa Y, et al. A Panton-Valentine leucocidine (PVL)-positive community – acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and another more-typical PVL-negative MRSA strains found in Japan. Journal of Clinical Microbiology 2005; 43: 3356–3363.
33.Rossney A, et al. The emergence and importation of diverse genotypes of methicillin-resistant Staphylococcus aureus (MRSA) harboring the Panton–Valentine leukocidin gene (pvl) reveal that pvl is a poor marker for community – acquired MRSA strains in Ireland. Journal of Clinical Microbiology 2007; 45: 2554–2563.
34.Peacock SJ, et al. Virulent combinations of adhesion and toxin genes in natural populations of Staphylococcus aureus. Infection and immunity 2002; 70: 4987–4996.
35.Zong Z, Peng C, Lü X. Diversity of SCCmec elements in methicillin-resistant coagulase-negative staphylococci clinical isolates PLoS One 2011; 6: e20191.
36.Ibrahem S, et al. Carriage of methicillin-resistant Staphylococci and their SCCmec types in a long-term-care facility. Journal of Clinical Microbiology 2009; 47: 32–37.
37.Lebeaux D, et al. Evolution of nasal carriage of methicillin-resistant coagulase-negative staphylococci in a remote population. Antimicrobial Agents and Chemotherapy 2012; 56: 315–323.
38.Song JH, et al. Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study. Journal of Antimicrobial Chemotherapy 2011; 66: 1061–1069.
39.Mediavilla JR, et al. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Current Opinion in Microbiology 2012; 15: 588–595.
40.Ammerlaan HS, et al. Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline. Journal of Antimicrobial Chemotherapy. 2011; 66: 2409–2417.
41.Huskins WC, et al. Intervention to reduce transmission of resistant bacteria in intensive care. New England Journal of Medicine 2011; 364: 1407–1418.